PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

208 hedge funds and large institutions have $3.76B invested in Pacira BioSciences in 2014 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
+17
Holders Change %
+8.9%
% of All Funds
6.04%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.26%
New
36
Increased
83
Reduced
69
Closed
18
Calls
$21.8M
Puts
$26.7M
Net Calls
-$4.92M
Net Calls Change
-$3.87M

Top Buyers

1
MCM
1
Marsico Capital Management
Colorado
$146M
2
RIM
2
RS Investment Management
California
$66.8M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$497M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$36.7M
5
O
5
OrbiMed
New York
$23.1M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$2.26M
2
VAM
2
Visium Asset Management
New York
$0
3
DCM
3
Daruma Capital Management
New York
$78.9M
4
Jennison Associates
4
Jennison Associates
New York
$219M
5
Millennium Management
5
Millennium Management
New York
$7.95M
Name Holding Trade Value Shares
Change 		Shares
Change %
PSC
226
Piper Sandler & Co
Minnesota
– -$9K -100 Closed
6 7 8 9
10